(Q56942132)

10

0 references

Alberto Mantovani

object named as

Alberto Mantovani

8

0 references

Margherita Zen

6

object named as

Margherita Zen

0 references

author name string

Nicola Bassi

1

0 references

Dorella Del Prete

2

0 references

Anna Ghirardello

3

0 references

Mariele Gatto

4

0 references

Monica Ceol

5

0 references

Silvano Bettio

7

0 references

Luca Iaccarino

Clinical Reviews in Allergy & Immunology

9

0 references

publication date

25 March 2015

0 references

published in

0 references

volume

49

0 references

issue

2

0 references

page(s)

217-226

0 references

cites work

SLE diagnosis and treatment: when early is early

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Optimizing outcome in SLE: treating-to-target and definition of treatment goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Autoantibodies in lupus: culprits or passive bystanders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

The long pentraxin 3 and its role in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Human renal epithelial cells produce the long pentraxin PTX3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

The classification of glomerulonephritis in systemic lupus erythematosus revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Involvement of the tubular ClC-type exchanger ClC-5 in glomeruli of human proteinuric nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Annual direct medical cost of active systemic lupus erythematosus in five European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Anti-DNA antibodies in the pathogenesis of lupus nephritis--the emerging mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Anti-C1q antibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Emerging and critical issues in the pathogenesis of lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

The role of defective clearance of apoptotic cells in systemic autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Pentraxins, anti-pentraxin antibodies, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Pentraxins, humoral innate immunity and tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Impaired endothelial function and elevated levels of pentraxin 3 in early-onset preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-015-8476-9

Long-term prognosis and causes of death in systemic lupus erythematosus

21 January 2018

1 reference

12 December 2020

Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis

1 reference

12 December 2020

Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of

1 reference

12 December 2020

Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus

1 reference

12 December 2020

Are anti-C1q antibodies different from other SLE autoantibodies?

1 reference

12 December 2020

Anti-C1q Autoantibodies in Lupus Nephritis

1 reference

12 December 2020